First Time Loading...

Nektar Therapeutics
NASDAQ:NKTR

Watchlist Manager
Nektar Therapeutics Logo
Nektar Therapeutics
NASDAQ:NKTR
Watchlist
Price: 1.83 USD 3.39%
Updated: May 16, 2024

Nektar Therapeutics
Selling, General & Administrative

Last Value
3-Years 3-Y CAGR
5-Years 5-Y CAGR
10-Years 10-Y CAGR
Quarterly
Annual
TTM
|

Nektar Therapeutics
Selling, General & Administrative Peer Comparison

Comparables:
JNJ
BMY
PFE
MRK
LLY

Competitive Selling, General & Administrative Analysis
Latest Figures & CAGR of Competitors

Company Selling, General & Administrative CAGR 3Y CAGR 5Y CAGR 10Y
Nektar Therapeutics
NASDAQ:NKTR
Selling, General & Administrative
-$76.5m
CAGR 3-Years
11%
CAGR 5-Years
3%
CAGR 10-Years
-7%
Johnson & Johnson
NYSE:JNJ
Selling, General & Administrative
-$21.9B
CAGR 3-Years
1%
CAGR 5-Years
1%
CAGR 10-Years
0%
Bristol-Myers Squibb Co
NYSE:BMY
Selling, General & Administrative
-$7.9B
CAGR 3-Years
-1%
CAGR 5-Years
-12%
CAGR 10-Years
-5%
Pfizer Inc
NYSE:PFE
Selling, General & Administrative
-$14.5B
CAGR 3-Years
-76%
CAGR 5-Years
N/A
CAGR 10-Years
0%
Merck & Co Inc
NYSE:MRK
Selling, General & Administrative
-$10.4B
CAGR 3-Years
-5%
CAGR 5-Years
-1%
CAGR 10-Years
1%
Eli Lilly and Co
NYSE:LLY
Selling, General & Administrative
-$7.6B
CAGR 3-Years
-7%
CAGR 5-Years
-4%
CAGR 10-Years
-1%

See Also

What is Nektar Therapeutics's Selling, General & Administrative?
Selling, General & Administrative
-76.5m USD

Based on the financial report for Mar 31, 2024, Nektar Therapeutics's Selling, General & Administrative amounts to -76.5m USD.

What is Nektar Therapeutics's Selling, General & Administrative growth rate?
Selling, General & Administrative CAGR 10Y
-7%

Over the last year, the Selling, General & Administrative growth was 11%. The average annual Selling, General & Administrative growth rates for Nektar Therapeutics have been 11% over the past three years , 3% over the past five years , and -7% over the past ten years .